GlassScriptPhysician profile
Bruce F Hermann
NPI 1952433955
$605.48
in general payments reported to CMS, 2019-2025
14 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $85.49 · 2021: $169 · 2022: $57.16 · 2023: $21.73 · 2024: $30.41 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $153.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $123.28 | 2019-2021 | |
| Smith+Nephew, INC. | $104.25 | 2019-2021 | |
| Mentor Worldwide LLC | $96.06 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Integra Lifesciences Corporation | $80.58 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Musculoskeletal Transplant Foundation INC. | $42.86 | 2023-2025 | |
| Abbvie INC. | $30.41 | 2024 | |
| Access Pro Medical, LLC | $25.65 | 2022 | |
| Tela Bio, INC. | $23.33 | 2022 | |
| Galderma Laboratories, L.P. | $19.17 | 2025 | |
| Tei Medical INC. | $17.11 | 2019 | |
| Melinta Therapeutics, LLC | $13.78 | 2019 | |
| Molnlycke Health Care US, LLC | $10.43 | 2021 | |
| Aroa Biosurgery Incorporated | $10.39 | 2020 | |
| Kerecis Limited | $8.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Hermann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.